Delivery Order SPE2DB22D1106-SPE2DB24FDNF5
Award Date 11/27/23
Potential Completion Date 11/28/23
Potential Value $2.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a firm fixed price delivery order for $1,782.86 from the Defense Logistics Agency (DLA) Troop Support Medical to supply XYOSTED 75 MG/0.5 ML auto-injectors. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 9, 2023. No set-aside designation was used for this award issued against an indefinite delivery contract held by Amerisourcebergen Drug Corp to...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order against an indefinite delivery contract held with the Defense Logistics Agency (DLA) Troop Support Medical. The $1,436.56 order is for the supply of 4562763964 XYOSTED 75 MG/0.5 ML auto-injectors to be delivered by November 9, 2023 to a location in Conshohocken, Pennsylvania. No set aside designation was applied to this order. As a prime contractor,...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,072 against an indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. The order is to supply 4562677025 XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products for delivery by November 2, 2023 to a location in Conshohocken, Pennsylvania. No set aside designation was applied to this award. As a prime contractor and leading pharmaceutical distributor, Amerisourcebergen Drug...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a delivery order valued at $754.26 by the Defense Logistics Agency to supply XYOSTED 75 MG/0.5 ML auto-injectors. The firm fixed price order is for performance from July 17-18, 2023 at the contractor's facility in Conshohocken, Pennsylvania. No subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely issues such requirements to support medical readiness for the...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $2,041.64 from the Defense Logistics Agency (DLA) to supply 4563032056 XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 8, 2023. No set-aside designation was applied to this award made against an indefinite-delivery contract held by Amerisourcebergen Drug Corp to provide pharmaceuticals and medical supplies to DLA Troop...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $2,526.93 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone medication. To be performed without a set aside designation, the order requires delivery of the specified pharmaceutical product to a DLA facility in Conshohocken, Pennsylvania by November 27, 2023. As a prime contractor supporting DLA...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,508.52 from the Defense Logistics Agency (DLA) Troop Support Medical to supply 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone medication. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all products delivered by November 6, 2023. This order was awarded against an indefinite-delivery contract held by Amerisourcebergen with no set-aside...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $251 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a medication used to treat conditions such as hypogonadism. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period concluding on August 29, 2023. No subcontractors or set aside designations were identified. The Defense Logistics...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $1,005.68 to supply 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania with all supplies delivered by October 31, 2023. This order was awarded against an unidentified medical supply vehicle and no set-aside provision was specified. As a leading...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,443.02 from the Defense Logistics Agency (DLA) to supply 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by November 2, 2023. This order was awarded against an indefinite-delivery contract held by Amerisourcebergen with DLA Troop Support Medical to provide pharmaceuticals and...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDNF5Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $2,061.48 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 4562911479 XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all work to be completed by November 28, 2023. No set aside designation was applied to this award made under an existing indefinite delivery contract to provide pharmaceuticals and medical supplies for DLA and Department of Defense medical treatment programs.
Generated 2/26/24, 9:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/27/23 |